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Background
Our knowledge about central changes underlying
depressive disorders is still incomplete, but disturbances
in monoaminergic neurotransmission are involved.
There is also increasing evidence for a possible role of
the neuropeptide galanin and its three G protein-
coupled receptors in the pathophysiology and treatment
of depression [1].
Methods
Using in situ hybridization we investigated whether tran-
scriptional processes in the galanin system may be
involved in the heightened depression-like behaviour of
HAB rats selectively bred for high trait anxiety as com-
pared with their low anxiety/depression (LAB) counter-
parts [2] and in the treatment responses to established
antidepressant drugs. Subsequently, the modulation of
depression-related behaviour by intra-cerebrally applied
galaninergic ligands was studied in HAB and LAB rats.
Results
The abundance of galanin mRNA was increased in the
paraventricular hypothalamus, the central amygdala and
the locus coeruleus (LC), but not in the dorsal raphe of
HAB as compared to LAB animals. Conversely, long-term
(42 days, p.o.) treatment with either desipramine, paroxe-
tine or tranylcypromine caused a general reduction in
galanin mRNA expression in the locus coeruleus (LC) of
unselected rats indicating a common response to antide-
pressant drug treatment while in the paraventricular
hypothalamus galanin mRNA was increased by tranylcy-
promine only. This observed common effect of the antide-
pressants on galanin mRNA in the LC is in contrast to the
finding in the HAB model raising the exciting possibility
that altered coerulear galanin mRNA expression may be
associated with depression-related behaviour. Indeed,
intra-LC galanin caused a pronounced increase in the
immobility of LAB rats indicating enhanced depression-
like behaviour while a galanin receptor antagonist reduced
immobility in HAB rats.
Conclusions
The present data suggest that depression-like behaviours
can be altered by interference with the galanin system
and, thus, the galanin system may represent an interest-
ing target for novel antidepressant pharmacotherapy. In
particular, its modulation in the LC, where galanin
highly coexists with noradrenaline, appears to be critical.
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